ERYTECH RAISES €10 MILLION IN PRIVATE PLACEMENT WITH U.S. AND EUROPEAN INVESTORS Post author:admERY Post published:December 8, 2016 Post category:Newsroom ERYTECH today announced the closing of a private placement of 793,877 ordinary shares to qualified investors in the United States and Europe for total gross proceeds of approximately €10 million. You Might Also Like ERYTECH to present at upcoming investor conferences May 20, 2013 ERYTECH reports positive Phase 2b data for eryaspase for the treatment of metastatic pancreatic cancer March 27, 2017 ERYTECH to Attend Upcoming Investor Conferences September 13, 2018
ERYTECH reports positive Phase 2b data for eryaspase for the treatment of metastatic pancreatic cancer March 27, 2017